Contribution: Industrial Research Assistance Program – Contributions to Firms
NanoVation Therapeutics Inc.
$304,000.00
UKRI Biomafnufacturing - 10095801 TCR-LNP - Combining long-circulating Lipid Nanoparticles with cancer-targeting T-Cell Receptors
FY 2024-25 · 2024-07-02
Summary
As part of the international consortium project TCR-LNP, this project will involve development of novel formulations of long-circulating lipid nanoparticles (lcLNP) with surface-ligated cancer tumor cell targeting T cell receptor (TCR) proteins to improve cancer-cell specific delivery of mRNA-based payloads.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
714010279
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-07-02 | 2024-25 | $448,000.00 |
| 1 | 2024-07-02 | 2024-25 | $304,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is -144,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de - 144 000 dollars.
Agreement End Date
2026-03-01
Agreement Number
1020099
Agreement Start Date
2024-07-02
Agreement Title
UKRI Biomafnufacturing - 10095801 TCR-LNP - Combining long-circulating Lipid Nanoparticles with cancer-targeting T-Cell Receptors
Agreement Title (French)
UKRI Biofabrication — 10095801 TCR-LNP — Combinaison de nanoparticules lipidiques à longue circulation avec des récepteurs de cellules T ciblant le cancer
Agreement Type
Contribution
Agreement Value
$304,000.00
Amendment Date
2025-01-24
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
As part of the international consortium project TCR-LNP, this project will involve development of novel formulations of long-circulating lipid nanoparticles (lcLNP) with surface-ligated cancer tumor cell targeting T cell receptor (TCR) proteins to improve cancer-cell specific delivery of mRNA-based payloads.
Description (French)
Dans le cadre du projet de consortium international TCR-LNP, ce projet portera sur le développement de nouvelles formulations de nanoparticules lipidiques à longue circulation (lcLNP) avec des protéines de récepteurs de cellules T (TCR) ciblées sur les cellules tumorales cancéreuses et liguées en surface, afin d’améliorer la délivrance spécifique aux cellules cancéreuses de charges utiles basées sur l’ARNm.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
714010279
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
NanoVation Therapeutics Inc.
Recipient Postal Code
V6T 1Z3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2024-2025-Q2-1020099
